Safely restarting GI endoscopy in the era of COVID-19-Reference-Cited by-同舟云学术

Safely restarting GI endoscopy in the era of COVID-19

Published:2020-06-05 Issue:12 Volume:69 Page:2063-2070
ISSN:0017-5749
Container-title:Gut
language:en
Short-container-title:Gut

Author:

Hayee Bu'Hussain^ORCID,Thoufeeq Mo,Rees Colin J,Penman Ian,East James

Publisher

BMJ

Subject

Gastroenterology

Reference64 articles.

1. Asymptomatic transmission, the Achilles' heel of current strategies to control Covid-19;Gandhi;N Engl J Med,2020

2. The British Society of Gastroenterology . Endoscopy activity and COVID-19: BSG and JAG guidance. Available: https://www.bsg.org.uk/covid-19-advice/endoscopy-activity-and-covid-19-bsg-and-jag-guidance/ [Accessed 26 Apr 2020].

3. Practice of endoscopy during COVID-19 pandemic: position statements of the Asian Pacific Society for Digestive Endoscopy (APSDE-COVID statements)

4. ESGE and ESGENA position statement on gastrointestinal endoscopy and the COVID-19 pandemic;Gralnek;Endoscopy,2020

5. Overview of guidance for endoscopy during the coronavirus disease 2019 pandemic;Lui;J Gastroenterol Hepatol,2020

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improving colorectal cancer screening - consumer-centred technological interventions to enhance engagement and participation amongst diverse cohorts;Clinics and Research in Hepatology and Gastroenterology;2023-01

2. A new system to prevent SARS-CoV-2 and microorganism air transmission through the air circulation system of endoscopes;Endoscopy International Open;2022-12

3. Einweginstrumente statt Mehrfachverwendung – Ist der Trend zu Einmalinstrumentarium in der Endoskopie ökologisch vertretbar?;Endo-Praxis;2022-12

4. 5G‐based remote magnetically controlled capsule endoscopy for examination of the stomach and small bowel;United European Gastroenterology Journal;2022-11-23

5. Treatment adaptations and outcomes of patients experiencing inflammatory bowel disease flares during the early COVID ‐19 pandemic: the PREPARE‐IBD multicentre cohort study;Alimentary Pharmacology & Therapeutics;2022-10-05